# OnCo record paper-hu-germline-mutations-pancreatic-cancer-risk-jama-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hu-germline-mutations-pancreatic-cancer-risk-jama-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hu-germline-mutations-pancreatic-cancer-risk-jama-2018" ;
  schema:name "Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer"@en ;
  schema:description "The 2018 Mayo Clinic study of 3,030 patients that found an inherited fault in one of six genes in 5.5 percent of all pancreatic cancers, including 5.2 percent of patients with no family history, which is why every patient is now offered a germline test."@en ;
  schema:url <https://onco.cc/key-papers/paper-hu-germline-mutations-pancreatic-cancer-risk-jama-2018/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2018.6228>, <https://pubmed.ncbi.nlm.nih.gov/29922827/> ;
  onco:tag "pancreatic-evidence" ;
  schema:sameAs <https://doi.org/10.1001/jama.2018.6228> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Hu C, Hart SN, Polley EC, et al." ;
  onco:related <https://onco.cc/key-papers/paper-caps-consortium-surveillance-recommendations-gut-2020/>, <https://onco.cc/key-papers/paper-polo-olaparib-maintenance-gbrca-pancreatic-nejm-2019/>, <https://onco.cc/biomarkers/brca-germline/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/brca-palb2-pdac/> ;
  onco:technologies <https://onco.cc/technologies/germline-testing/>, <https://onco.cc/technologies/pancreatic-surveillance/> ;
  onco:targets <https://onco.cc/targets/brca/>, <https://onco.cc/targets/atm/>, <https://onco.cc/targets/cdkn2a/>, <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/mlh1/> ;
  onco:institutions <https://onco.cc/institutions/mayo-clinic/> ;
  onco:pathways <https://onco.cc/pathways/ddr/> ;
  onco:terms <https://onco.cc/terms/gbrca-mutation/>, <https://onco.cc/terms/germline-vs-somatic/>, <https://onco.cc/terms/hereditary-cancer-syndromes/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-hereditary-risk/> ;
  onco:journals <https://onco.cc/journals/jama/> .